MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction
Concerning adenocarcinomas of the esophagogastric junction, neoadjuvant chemotherapy is regularly implemented, but patients’ response varies greatly, with some cases showing no therapeutic effect, being deemed as chemoresistant. Small, noncoding RNAs (miRNAs) have evolved as key players in biologica...
Main Authors: | Christina Just, Juliana Knief, Pamela Lazar-Karsten, Ekaterina Petrova, Richard Hummel, Christoph Röcken, Ulrich Wellner, Christoph Thorns |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2019/4903152 |
Similar Items
-
Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
by: Xin Hu, et al.
Published: (2021-05-01) -
Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
by: Haijun Li, et al.
Published: (2017-01-01) -
Surgical principles for optimal treatment of esophagogastric junction adenocarcinoma
by: Tamar Nobel, et al.
Published: (2019-07-01) -
Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study
by: Haitao Xu, et al.
Published: (2020-06-01) -
Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction
by: Yasuaki Nagami, et al.
Published: (2014-03-01)